You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RAPP Sale Disclosure
Ceesay Abraham · SEC Form 4 · Filed Aug 12, 2026
Sale
Calculated transaction value
$651.49K
Ceesay Abraham Chief Executive Officer
RAPP
Rapport Therapeutics
RAPP
Transaction date
Aug 10, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 2 days later
RAPP daily price context
Close on/before transaction
$46.98
Aug 10, 2026
First close after public filing
$47.36
Aug 13, 2026
30-day return after filing
-7.9%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 14,171 shares @ $45.97
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-346995
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$2.43M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP | Sale | Aug 11, 2026 | $171.84K |
| Rapport Therapeutics, Inc. RAPP | Sale | Aug 11, 2026 | $936.85K |
| Rapport Therapeutics, Inc. RAPP | Sale | Aug 11, 2026 | $281.72K |
| Rapport Therapeutics, Inc. RAPP | Sale | Aug 10, 2026 | $391.28K |
| Rapport Therapeutics, Inc. RAPP Current | Sale | Aug 10, 2026 | $651.49K |